DRUG · Unmapped registry intervention
SGLT2 inhibitor
Find medicine records ·
Find other trials using this name
Clinical trial
Mechanism of SGLT2 Inhibition in the Kidney
NCT06291155
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedMechanism of SGLT2 Inhibition in the Kidney
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
SGLT2 inhibitorDRUG
Sponsors & collaborators
University of Michiganlead sponsor
University of Colorado, Denvercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06291155 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.